Searched for
ANTIVIRAL FAVIPIRAVIR
Hantavirus: Britain secures experimental Japanese drug to strengthen responseBritain has received experimental favipiravir from Japan to treat a deadly hantavirus outbreak. The drug is not licensed in the UK and its ...- Favipiravir drug shows promise against Chandipura virus in preclinical studies by NIVFavipiravir offers hope against the Chandipura virus. Studies by the National Institute of Virology show promising results. The drug reduce...
- Bharat Parenterals gets DCGI nod for favipiravir oral suspensionThe company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parente...
- Remdesivir has no impact on Covid mortality, don't panic-buy: DoctorsThe rush to secure doses of the antiviral remdesivir is unfounded as it has little or no impact on survival in those hospitalised with Covi...
- Study shows Favipiravir provides multiple benefits in COVID-19 treatment: GlenmarkThe Phase 3 study with Favipiravir, sold under the brand name FabiFlu, by the company was conducted in 150 patients, it added. Favipiravir ...
- COVID-19: Favipiravir shows hope in Mumbai trialWhile the WHO last week recommended that antiviral remdesivir not be used for severely ill Covid-19 patients, Mumbai doctors published the ...
- No 'significant' benefit of favipiravir, umifenovir combination in Covid treatment: GlenmarkGlenmark had in May intimated the study to examine whether early administration of a combination of Favipiravir and Umifenovir enhances ant...
- After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
- Hyderabad pharmaceutical Raghava Life Sciences gets nod to make Favipiravir APIThe Hyderabad-based producer of active pharmaceutical ingredients (APIs) had in May commercialised the Favipiravir API and is currently dis...
- Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tabletFavipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...
- Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75 per tabletIn a regulatory filing Glenmark announced a price reduction of 27 per cent for FabiFlu. The new maximum retail price (MRP) is Rs 75 per tab...
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Raghava Life Sciences in talks with formulators for potential Covid drug FavipiravirFavipiravir, a generic version of Avigan that is used to treat influenza in Japan, is being studied as an experimental drug in treating the...
- Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...
- Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...
- Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatmentStrides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...
Load More
